| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | zinc ion binding | RAG1 SETMAR TRAF5 TRIM42 TRIM61 MMP23B ZFHX2 SIAH1 TRIM6 PTER TRIM60 | 9.92e-06 | 891 | 50 | 11 | GO:0008270 |
| GeneOntologyMolecularFunction | transition metal ion binding | RAG1 SETMAR TRAF5 TRIM42 TRIM61 MMP23B ZFHX2 SIAH1 TRIM6 PTER MUC2 TRIM60 | 2.76e-05 | 1189 | 50 | 12 | GO:0046914 |
| GeneOntologyMolecularFunction | calcium ion binding | 8.83e-05 | 749 | 50 | 9 | GO:0005509 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 8.16e-04 | 17 | 50 | 2 | GO:0042813 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 8.73e-04 | 815 | 50 | 8 | GO:0042803 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.25e-03 | 188 | 50 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 2.13e-03 | 102 | 50 | 3 | GO:0001540 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 2.33e-03 | 372 | 50 | 5 | GO:0061630 | |
| GeneOntologyCellularComponent | extracellular matrix | 6.14e-07 | 656 | 53 | 11 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 6.33e-07 | 658 | 53 | 11 | GO:0030312 | |
| GeneOntologyCellularComponent | Golgi lumen | 8.26e-06 | 109 | 53 | 5 | GO:0005796 | |
| HumanPheno | Scarring | 2.71e-05 | 102 | 19 | 5 | HP:0100699 | |
| Domain | VWC_out | 1.40e-09 | 19 | 51 | 5 | SM00215 | |
| Domain | EGF_Ca-bd_CS | 7.86e-09 | 97 | 51 | 7 | IPR018097 | |
| Domain | EGF_CA | 9.07e-09 | 99 | 51 | 7 | PS01187 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.46e-08 | 106 | 51 | 7 | IPR000152 | |
| Domain | EGF_CA | 3.89e-08 | 122 | 51 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.36e-08 | 124 | 51 | 7 | IPR001881 | |
| Domain | VWFC_1 | 4.39e-08 | 36 | 51 | 5 | PS01208 | |
| Domain | VWC | 5.82e-08 | 38 | 51 | 5 | SM00214 | |
| Domain | VWFC_2 | 5.82e-08 | 38 | 51 | 5 | PS50184 | |
| Domain | VWF_dom | 9.78e-08 | 42 | 51 | 5 | IPR001007 | |
| Domain | EGF_CA | 1.22e-07 | 86 | 51 | 6 | PF07645 | |
| Domain | Growth_fac_rcpt_ | 2.11e-07 | 156 | 51 | 7 | IPR009030 | |
| Domain | EGF_3 | 2.23e-07 | 235 | 51 | 8 | PS50026 | |
| Domain | ASX_HYDROXYL | 3.00e-07 | 100 | 51 | 6 | PS00010 | |
| Domain | EGF-like_dom | 3.46e-07 | 249 | 51 | 8 | IPR000742 | |
| Domain | EGF_1 | 4.15e-07 | 255 | 51 | 8 | PS00022 | |
| Domain | EGF-like_CS | 4.95e-07 | 261 | 51 | 8 | IPR013032 | |
| Domain | EGF_2 | 5.55e-07 | 265 | 51 | 8 | PS01186 | |
| Domain | EGF | 1.17e-06 | 126 | 51 | 6 | PF00008 | |
| Domain | EGF | 3.30e-06 | 235 | 51 | 7 | SM00181 | |
| Domain | TIL | 4.15e-06 | 12 | 51 | 3 | PF01826 | |
| Domain | C8 | 4.15e-06 | 12 | 51 | 3 | PF08742 | |
| Domain | Znf_RING_CS | 5.24e-06 | 163 | 51 | 6 | IPR017907 | |
| Domain | Unchr_dom_Cys-rich | 5.38e-06 | 13 | 51 | 3 | IPR014853 | |
| Domain | C8 | 5.38e-06 | 13 | 51 | 3 | SM00832 | |
| Domain | TIL_dom | 6.84e-06 | 14 | 51 | 3 | IPR002919 | |
| Domain | VWD | 1.05e-05 | 16 | 51 | 3 | SM00216 | |
| Domain | VWF_type-D | 1.05e-05 | 16 | 51 | 3 | IPR001846 | |
| Domain | VWFD | 1.05e-05 | 16 | 51 | 3 | PS51233 | |
| Domain | VWD | 1.05e-05 | 16 | 51 | 3 | PF00094 | |
| Domain | LRRNT | 1.31e-05 | 53 | 51 | 4 | PF01462 | |
| Domain | ZF_RING_1 | 1.34e-05 | 291 | 51 | 7 | PS00518 | |
| Domain | CTCK_1 | 1.52e-05 | 18 | 51 | 3 | PS01185 | |
| Domain | ZF_RING_2 | 1.56e-05 | 298 | 51 | 7 | PS50089 | |
| Domain | RING | 1.81e-05 | 305 | 51 | 7 | SM00184 | |
| Domain | Znf_RING | 2.77e-05 | 326 | 51 | 7 | IPR001841 | |
| Domain | CT | 2.85e-05 | 22 | 51 | 3 | SM00041 | |
| Domain | zf-C3HC4 | 3.11e-05 | 223 | 51 | 6 | PF00097 | |
| Domain | Cys_knot_C | 4.23e-05 | 25 | 51 | 3 | IPR006207 | |
| Domain | CTCK_2 | 4.23e-05 | 25 | 51 | 3 | PS01225 | |
| Domain | zf-B_box | 4.42e-05 | 72 | 51 | 4 | PF00643 | |
| Domain | cEGF | 4.77e-05 | 26 | 51 | 3 | IPR026823 | |
| Domain | cEGF | 4.77e-05 | 26 | 51 | 3 | PF12662 | |
| Domain | VWC | 5.99e-05 | 28 | 51 | 3 | PF00093 | |
| Domain | ZF_BBOX | 6.69e-05 | 80 | 51 | 4 | PS50119 | |
| Domain | Znf_B-box | 7.03e-05 | 81 | 51 | 4 | IPR000315 | |
| Domain | LRR_8 | 1.01e-04 | 171 | 51 | 5 | PF13855 | |
| Domain | Znf_C3HC4_RING-type | 1.04e-04 | 172 | 51 | 5 | IPR018957 | |
| Domain | WxxW_domain | 1.09e-04 | 6 | 51 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 1.09e-04 | 6 | 51 | 2 | PF13330 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.19e-04 | 177 | 51 | 5 | IPR003591 | |
| Domain | LRR_TYP | 1.19e-04 | 177 | 51 | 5 | SM00369 | |
| Domain | LRRNT | 1.47e-04 | 98 | 51 | 4 | IPR000372 | |
| Domain | LRRNT | 1.47e-04 | 98 | 51 | 4 | SM00013 | |
| Domain | Znf_RING/FYVE/PHD | 2.35e-04 | 459 | 51 | 7 | IPR013083 | |
| Domain | Ldl_recept_b | 6.51e-04 | 14 | 51 | 2 | PF00058 | |
| Domain | LDLRB | 6.51e-04 | 14 | 51 | 2 | PS51120 | |
| Domain | - | 6.51e-04 | 14 | 51 | 2 | 3.90.890.10 | |
| Domain | - | 6.51e-04 | 14 | 51 | 2 | 2.60.210.10 | |
| Domain | LY | 7.50e-04 | 15 | 51 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 7.50e-04 | 15 | 51 | 2 | IPR000033 | |
| Domain | Leu-rich_rpt | 8.44e-04 | 271 | 51 | 5 | IPR001611 | |
| Domain | SIAH-type | 8.56e-04 | 16 | 51 | 2 | IPR013323 | |
| Domain | BBOX | 8.85e-04 | 69 | 51 | 3 | SM00336 | |
| Domain | - | 9.62e-04 | 71 | 51 | 3 | 4.10.45.10 | |
| Domain | - | 1.35e-03 | 449 | 51 | 6 | 3.30.40.10 | |
| Domain | - | 1.79e-03 | 321 | 51 | 5 | 3.80.10.10 | |
| Domain | TRAF-like | 1.94e-03 | 24 | 51 | 2 | IPR008974 | |
| Domain | L_dom-like | 1.96e-03 | 328 | 51 | 5 | IPR032675 | |
| Domain | LRR | 2.19e-03 | 201 | 51 | 4 | PS51450 | |
| Pathway | REACTOME_DEFECTIVE_ST3GAL3_CAUSES_MCT12_AND_EIEE15 | 7.12e-07 | 8 | 34 | 3 | M27264 | |
| Pathway | REACTOME_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D | 7.12e-07 | 8 | 34 | 3 | M27265 | |
| Pathway | REACTOME_DEFECTIVE_CHST6_CAUSES_MCDC1 | 7.12e-07 | 8 | 34 | 3 | M27262 | |
| Pathway | REACTOME_KERATAN_SULFATE_DEGRADATION | 5.72e-06 | 15 | 34 | 3 | M691 | |
| Pathway | REACTOME_KERATAN_SULFATE_DEGRADATION | 5.72e-06 | 15 | 34 | 3 | MM14799 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.20e-05 | 143 | 34 | 5 | M27275 | |
| Pathway | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | 4.03e-05 | 28 | 34 | 3 | M670 | |
| Pathway | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | 4.03e-05 | 28 | 34 | 3 | MM14798 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 8.67e-05 | 36 | 34 | 3 | M690 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 8.67e-05 | 36 | 34 | 3 | MM14632 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM | 1.28e-04 | 41 | 34 | 3 | M27257 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LIGHT_HVEM_NFKB_SIGNALING_PATHWAY | 2.51e-04 | 10 | 34 | 2 | M47599 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.08e-04 | 250 | 34 | 5 | M27554 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HSV_GD_TO_HVEM_NFKB_SIGNALING_PATHWAY | 3.67e-04 | 12 | 34 | 2 | M47600 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_NEF_TO_TNF_NFKB_SIGNALING_PATHWAY | 5.05e-04 | 14 | 34 | 2 | M47567 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_TNF_NFKB_SIGNALING_PATHWAY | 5.81e-04 | 15 | 34 | 2 | M47566 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TNF_NFKB_SIGNALING_PATHWAY | 6.63e-04 | 16 | 34 | 2 | M47453 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.15e-03 | 21 | 34 | 2 | MM15706 | |
| Pubmed | Quantitative trait analysis of the development of pulmonary tolerance to inhaled zinc oxide in mice. | 6.66e-08 | 6 | 53 | 3 | 16026622 | |
| Pubmed | 5.47e-07 | 11 | 53 | 3 | 12796502 | ||
| Pubmed | 2.10e-06 | 136 | 53 | 5 | 25429064 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 30666958 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 21107311 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 12433986 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 12160726 | ||
| Pubmed | [Interleukin-1beta induces MUC2/MUC5B gene expression in human nasal epithelial cells]. | 2.28e-06 | 2 | 53 | 2 | 20873538 | |
| Pubmed | DR3 regulates negative selection during thymocyte development. | 2.28e-06 | 2 | 53 | 2 | 11313471 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 18804458 | ||
| Pubmed | 6.61e-06 | 24 | 53 | 3 | 9096311 | ||
| Pubmed | TRAF5 is a downstream target of MAVS in antiviral innate immune signaling. | 6.83e-06 | 3 | 53 | 2 | 20161788 | |
| Pubmed | Establishment of tumor-associated immunity requires interaction of heat shock proteins with CD91. | 6.83e-06 | 3 | 53 | 2 | 24778318 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 16399796 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 19718741 | ||
| Pubmed | Robo1 modulates proliferation and neurogenesis in the developing neocortex. | 9.52e-06 | 27 | 53 | 3 | 24741061 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 25638393 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 17471237 | ||
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 1.36e-05 | 4 | 53 | 2 | 22269464 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 14984930 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 23249391 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 30951556 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 11084649 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 1.36e-05 | 4 | 53 | 2 | 29869461 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 38462037 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 21596555 | ||
| Pubmed | Evolution of Human Brain Size-Associated NOTCH2NL Genes Proceeds toward Reduced Protein Levels. | 1.36e-05 | 4 | 53 | 2 | 32330268 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 23807779 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 12676567 | ||
| Pubmed | Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis. | 2.27e-05 | 5 | 53 | 2 | 29856954 | |
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 2.27e-05 | 5 | 53 | 2 | 11062147 | |
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 24840470 | ||
| Pubmed | Differential expression of MUC genes in endometrial and cervical tissues and tumors. | 2.27e-05 | 5 | 53 | 2 | 16188033 | |
| Pubmed | Generalized immune activation as a direct result of activated CD4+ T cell killing. | 2.27e-05 | 5 | 53 | 2 | 19943952 | |
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 19110483 | ||
| Pubmed | A central role for Notch in effector CD8(+) T cell differentiation. | 3.40e-05 | 6 | 53 | 2 | 25344724 | |
| Pubmed | A role for BATF3 in TH9 differentiation and T-cell-driven mucosal pathologies. | 3.40e-05 | 6 | 53 | 2 | 30617301 | |
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 9177772 | ||
| Pubmed | 3.42e-05 | 41 | 53 | 3 | 22675208 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.84e-05 | 248 | 53 | 5 | 24006456 | |
| Pubmed | 4.76e-05 | 7 | 53 | 2 | 32060138 | ||
| Pubmed | 6.23e-05 | 50 | 53 | 3 | 24449835 | ||
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 11847210 | ||
| Pubmed | Chromosome localization of the mouse zonadhesin gene and the human zonadhesin gene (ZAN). | 6.34e-05 | 8 | 53 | 2 | 9126492 | |
| Pubmed | Coordination of Cellular Dynamics Contributes to Tooth Epithelium Deformations. | 8.15e-05 | 9 | 53 | 2 | 27588418 | |
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 31350179 | ||
| Pubmed | LDL receptor-related protein as a component of the midkine receptor. | 8.15e-05 | 9 | 53 | 2 | 10772929 | |
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 11092979 | ||
| Pubmed | MAVS activates TBK1 and IKKε through TRAFs in NEMO dependent and independent manner. | 8.15e-05 | 9 | 53 | 2 | 29125880 | |
| Pubmed | 8.92e-05 | 153 | 53 | 4 | 25037231 | ||
| Pubmed | A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. | 1.02e-04 | 10 | 53 | 2 | 18079694 | |
| Pubmed | 1.02e-04 | 10 | 53 | 2 | 24971483 | ||
| Pubmed | MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. | 1.24e-04 | 11 | 53 | 2 | 23951545 | |
| Pubmed | 1.24e-04 | 11 | 53 | 2 | 10575226 | ||
| Pubmed | 1.25e-04 | 167 | 53 | 4 | 22159717 | ||
| Pubmed | 1.76e-04 | 13 | 53 | 2 | 37936982 | ||
| Pubmed | TGFbeta2 in corneal morphogenesis during mouse embryonic development. | 1.76e-04 | 13 | 53 | 2 | 11784073 | |
| Pubmed | SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin. | 2.05e-04 | 14 | 53 | 2 | 28424516 | |
| Pubmed | 2.36e-04 | 15 | 53 | 2 | 15615879 | ||
| Pubmed | A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion. | 2.36e-04 | 15 | 53 | 2 | 27339979 | |
| Pubmed | 2.53e-04 | 371 | 53 | 5 | 25241761 | ||
| Pubmed | 2.74e-04 | 591 | 53 | 6 | 15231748 | ||
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 3.43e-04 | 18 | 53 | 2 | 18834073 | |
| Pubmed | 3.43e-04 | 18 | 53 | 2 | 19403103 | ||
| Pubmed | 3.83e-04 | 19 | 53 | 2 | 34988124 | ||
| Pubmed | 3.83e-04 | 19 | 53 | 2 | 25691540 | ||
| Pubmed | 3.83e-04 | 19 | 53 | 2 | 19139842 | ||
| Pubmed | 4.19e-04 | 95 | 53 | 3 | 20568250 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 4.40e-04 | 1201 | 53 | 8 | 35696571 | |
| Pubmed | 4.70e-04 | 21 | 53 | 2 | 17303760 | ||
| Pubmed | 4.70e-04 | 21 | 53 | 2 | 21703454 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 5.01e-04 | 101 | 53 | 3 | 20551380 | |
| Pubmed | 5.16e-04 | 22 | 53 | 2 | 29634390 | ||
| Pubmed | 5.65e-04 | 23 | 53 | 2 | 14701881 | ||
| Pubmed | Wnt5a signaling mediates biliary differentiation of fetal hepatic stem/progenitor cells in mice. | 5.65e-04 | 23 | 53 | 2 | 23386589 | |
| Pubmed | 5.88e-04 | 251 | 53 | 4 | 29031500 | ||
| Pubmed | Complexes of tetraspanins with integrins: more than meets the eye. | 6.16e-04 | 24 | 53 | 2 | 11739647 | |
| Pubmed | 6.87e-04 | 1285 | 53 | 8 | 35914814 | ||
| Pubmed | Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. | 7.00e-04 | 263 | 53 | 4 | 19773279 | |
| Pubmed | 7.23e-04 | 26 | 53 | 2 | 14960276 | ||
| Pubmed | 7.88e-04 | 118 | 53 | 3 | 21078624 | ||
| Pubmed | 9.01e-04 | 29 | 53 | 2 | 27358050 | ||
| Pubmed | Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. | 9.64e-04 | 30 | 53 | 2 | 21946350 | |
| Pubmed | 1.03e-03 | 31 | 53 | 2 | 30254141 | ||
| Pubmed | 1.03e-03 | 31 | 53 | 2 | 22274697 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.16e-03 | 135 | 53 | 3 | 28675934 | |
| Pubmed | 1.24e-03 | 34 | 53 | 2 | 36543770 | ||
| Pubmed | 1.31e-03 | 35 | 53 | 2 | 11013070 | ||
| Pubmed | 1.46e-03 | 146 | 53 | 3 | 27068509 | ||
| Pubmed | Neural deletion of Tgfbr2 impairs angiogenesis through an altered secretome. | 1.47e-03 | 37 | 53 | 2 | 24990151 | |
| Interaction | ZNF627 interactions | 1.41e-05 | 20 | 48 | 3 | int:ZNF627 | |
| Interaction | ZNF430 interactions | 4.44e-05 | 29 | 48 | 3 | int:ZNF430 | |
| Interaction | CILP2 interactions | 5.44e-05 | 31 | 48 | 3 | int:CILP2 | |
| Interaction | MDK interactions | 6.50e-05 | 91 | 48 | 4 | int:MDK | |
| Cytoband | 4q32.3 | 7.44e-04 | 34 | 54 | 2 | 4q32.3 | |
| Cytoband | 1q32 | 1.54e-03 | 49 | 54 | 2 | 1q32 | |
| GeneFamily | Small leucine rich repeat proteoglycans | 2.01e-06 | 12 | 39 | 3 | 573 | |
| GeneFamily | Ring finger proteins | 2.51e-05 | 275 | 39 | 6 | 58 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 5.11e-05 | 95 | 39 | 4 | 59 | |
| GeneFamily | CD molecules|Mucins | 9.28e-04 | 21 | 39 | 2 | 648 | |
| GeneFamily | CD molecules|Tetraspanins | 2.29e-03 | 33 | 39 | 2 | 768 | |
| GeneFamily | LIM domain containing | 7.18e-03 | 59 | 39 | 2 | 1218 | |
| Coexpression | NABA_CORE_MATRISOME | 1.50e-10 | 270 | 53 | 10 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 4.00e-09 | 275 | 53 | 9 | M5884 | |
| Coexpression | NABA_MATRISOME | TGFB2 FBLN5 FNDC7 CRIM1 OTOGL PRELP SLIT3 MMP23B KERA NID1 MUC5B OMD VWCE MUC2 | 8.39e-09 | 1008 | 53 | 14 | MM17056 |
| Coexpression | BOQUEST_STEM_CELL_UP | 5.23e-08 | 261 | 53 | 8 | M1834 | |
| Coexpression | NABA_MATRISOME | TGFB2 FBLN5 FNDC7 CRIM1 PRELP SLIT3 MMP23B KERA NID1 MUC5B OMD VWCE MUC2 | 9.22e-08 | 1026 | 53 | 13 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.13e-07 | 191 | 53 | 7 | MM17059 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 2.62e-06 | 194 | 53 | 6 | M39122 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.78e-06 | 196 | 53 | 6 | M3008 | |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_DN | 1.31e-05 | 546 | 53 | 8 | M3837 | |
| Coexpression | NABA_PROTEOGLYCANS | 4.88e-05 | 35 | 53 | 3 | M5882 | |
| Coexpression | NABA_PROTEOGLYCANS | 5.32e-05 | 36 | 53 | 3 | MM17061 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 5.82e-05 | 493 | 53 | 7 | M19391 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 1.80e-04 | 54 | 53 | 3 | M4737 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 3.57e-06 | 97 | 51 | 5 | GSM777046_100 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | 1.21e-05 | 456 | 51 | 8 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.02e-04 | 455 | 51 | 7 | GSM777055_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.18e-04 | 466 | 51 | 7 | GSM777050_500 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.36e-11 | 192 | 54 | 8 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.08e-11 | 194 | 54 | 8 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.08e-11 | 194 | 54 | 8 | 29f83cdd63314fff41258937d70b881a5503bfcc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.08e-11 | 194 | 54 | 8 | d3db241ea316bbcde6d16618193b474591ad5ce4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.46e-11 | 195 | 54 | 8 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-10 | 197 | 54 | 8 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-10 | 199 | 54 | 8 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-10 | 199 | 54 | 8 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-10 | 200 | 54 | 8 | 17ffdbc13332bd3ed1d54abcd7af20267dd4b234 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-10 | 200 | 54 | 8 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-10 | 200 | 54 | 8 | 2e4ab7fbd94d3d865ef6188d3b4916d2bf1b8d89 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-10 | 200 | 54 | 8 | 665df8391d2ebcfc6536318612f4992852b5e2b8 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-10 | 200 | 54 | 8 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-10 | 200 | 54 | 8 | f74b9b0e27afedd589e828d30194e8417029817a | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-10 | 200 | 54 | 8 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-10 | 200 | 54 | 8 | 9dd2eb70c1cc146935f5aff27373dfc65cb8c098 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-10 | 200 | 54 | 8 | 5fdca7959134a5c8e06e5d6d14aafe34b963aef2 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-09 | 182 | 54 | 7 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-09 | 186 | 54 | 7 | ff6ccfdf2509f96caa10281c29a95b432f6c6dcc | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-09 | 186 | 54 | 7 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-09 | 187 | 54 | 7 | 2c145e9d11424939dd99012a8cedf5d998b966e9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-09 | 189 | 54 | 7 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-09 | 191 | 54 | 7 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-09 | 192 | 54 | 7 | fc940f91ff8e051631dbf25e6e8d73cf8337eccb | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-09 | 192 | 54 | 7 | 7a2e79490e4f7058bb76b46c45b5df9f729e3146 | |
| ToppCell | facs-Trachea-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-09 | 192 | 54 | 7 | e8af6ad1ae99cae13a82d0d8d7f38af9b777f0ba | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-09 | 193 | 54 | 7 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-09 | 193 | 54 | 7 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-09 | 193 | 54 | 7 | 76f0f8569255d6cdf1e3b8e954cae72e71f87157 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-09 | 193 | 54 | 7 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-09 | 193 | 54 | 7 | f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-09 | 193 | 54 | 7 | 85faf6c5ce4769615a4eca036e2ba307e176bb52 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.58e-09 | 193 | 54 | 7 | 25248b8e65d558b1a96a87c93e3e5b4c0ba168fe | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.58e-09 | 193 | 54 | 7 | f1f1097204e07a7bed416425b8256942038a734f | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-09 | 193 | 54 | 7 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-09 | 193 | 54 | 7 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-09 | 193 | 54 | 7 | 110a7d2ba7d066c2be38be98b643b76c520dd980 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-09 | 194 | 54 | 7 | da926441053b499cb5107ccb116fb1b3844d82b7 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-09 | 194 | 54 | 7 | 54a7f693966b5c02f6b248950ddb5fa32af3ae67 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-09 | 194 | 54 | 7 | f34b3bbdebf56f66ff499e390e5515a4a4093f90 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.84e-09 | 195 | 54 | 7 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.84e-09 | 195 | 54 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.84e-09 | 195 | 54 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | IPF-Stromal-Fibroblast|IPF / Disease state, Lineage and Cell class | 3.98e-09 | 196 | 54 | 7 | f7ae604ba32b322d86d68b2b54892e7c6ab06c49 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.98e-09 | 196 | 54 | 7 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | Control-Stromal-Fibroblast|Control / Disease state, Lineage and Cell class | 3.98e-09 | 196 | 54 | 7 | 7ca94477498a84cafcdd9933ee92a6cbde76c70e | |
| ToppCell | Control-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 3.98e-09 | 196 | 54 | 7 | 1ec7a4daa51b3156db97e1fd6cb925ad311bb4b5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.13e-09 | 197 | 54 | 7 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.13e-09 | 197 | 54 | 7 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 4.27e-09 | 198 | 54 | 7 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.27e-09 | 198 | 54 | 7 | aae663c6da70b6e716edeed50cc7d3962d78e697 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.42e-09 | 199 | 54 | 7 | 5a425e7d11c5911ff5855c27a7f058a7ed7abbb0 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.42e-09 | 199 | 54 | 7 | 66545eb7f65e450b742628fd431956e13330a0d3 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.42e-09 | 199 | 54 | 7 | 4e128c705ad36fd840582848f278770f356fcc8b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.42e-09 | 199 | 54 | 7 | a538da095ba996ee96e263442cf5b6ba9178f3d4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.42e-09 | 199 | 54 | 7 | 4032f03a4165f5f2a90ef1d8315cc743ce9075bb | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.42e-09 | 199 | 54 | 7 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.42e-09 | 199 | 54 | 7 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.58e-09 | 200 | 54 | 7 | 933b5b400e48a511ba0a056be1d33d3610b5f10d | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.58e-09 | 200 | 54 | 7 | 8d75ce89393df452defacf2ec9a5bd4b7708afbb | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.58e-09 | 200 | 54 | 7 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.58e-09 | 200 | 54 | 7 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.58e-09 | 200 | 54 | 7 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | 343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.58e-09 | 200 | 54 | 7 | 376c1a77031e090be96948b47c78ac0d393f5775 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.58e-09 | 200 | 54 | 7 | cfea2f9d85646c9b722150551ff2e8fc4f6cc98a | |
| ToppCell | 367C-Fibroblasts-Fibroblast-E-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.58e-09 | 200 | 54 | 7 | 57b9d6aa2265ab178a5886f36ecc66115bd382a8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.58e-09 | 200 | 54 | 7 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.58e-09 | 200 | 54 | 7 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.58e-09 | 200 | 54 | 7 | 87177c973e722ac7d9ee503b9cfacd84fc67865d | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.58e-09 | 200 | 54 | 7 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.58e-09 | 200 | 54 | 7 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.58e-09 | 200 | 54 | 7 | 3fa7d9ea67f9cc55478d085da53babd03dbe9bb1 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.58e-09 | 200 | 54 | 7 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.58e-09 | 200 | 54 | 7 | cbf6a6c3db88bac37bd084a3a914b12b3af524eb | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.58e-09 | 200 | 54 | 7 | ef30f9b68bfdb8d947ed399603e4dd0d5ff0144d | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.58e-09 | 200 | 54 | 7 | fd92d8250c6ad1e8bb46b303ac37f8dcf80387d8 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.58e-09 | 200 | 54 | 7 | b28bfe6eb96b4db9cb27f0fc8fc39259c125f05e | |
| ToppCell | Fibroblast|World / shred by cell class for parenchyma | 4.58e-09 | 200 | 54 | 7 | dec9ce1bc2571197003596f32e5f742ede72aa79 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.58e-09 | 200 | 54 | 7 | f6cf98aad53aa8b3fa02cf874d6f7cd75530a213 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.58e-09 | 200 | 54 | 7 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-E|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.58e-09 | 200 | 54 | 7 | ddfbc004e7bd2fd3f11f046ed8fc049277160547 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.58e-09 | 200 | 54 | 7 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.58e-09 | 200 | 54 | 7 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.58e-09 | 200 | 54 | 7 | 5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 4.58e-09 | 200 | 54 | 7 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.58e-09 | 200 | 54 | 7 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.58e-09 | 200 | 54 | 7 | 87953ea65ff2a01485e13dd49d993ae6ae679cbf | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.27e-08 | 176 | 54 | 6 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.27e-08 | 176 | 54 | 6 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 8.04e-08 | 179 | 54 | 6 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.58e-08 | 181 | 54 | 6 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.58e-08 | 181 | 54 | 6 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.87e-08 | 182 | 54 | 6 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.87e-08 | 182 | 54 | 6 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.87e-08 | 182 | 54 | 6 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.16e-08 | 183 | 54 | 6 | 2beb5414958d38a5341870d55229f3b1707e76bf | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 9.46e-08 | 184 | 54 | 6 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.77e-08 | 185 | 54 | 6 | e1fbec55b71f604189eb2431768fadbaa0453a83 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.77e-08 | 185 | 54 | 6 | 9d933cd5ebc8368fd37aa83113d2dfa6938ff72d | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-08 | 185 | 54 | 6 | 785c55d39909fac74415f24427979691e7e694e6 | |
| Drug | Ethotoin [86-35-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 5.36e-06 | 195 | 52 | 6 | 6052_UP | |
| Drug | Ganciclovir [82410-32-0]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 5.52e-06 | 196 | 52 | 6 | 3368_UP | |
| Drug | thioridazine hydrochloride; Up 200; 1uM; MCF7; HG-U133A | 5.68e-06 | 197 | 52 | 6 | 422_UP | |
| Drug | 0175029-0000 [211245-78-2]; Up 200; 1uM; PC3; HT_HG-U133A | 5.68e-06 | 197 | 52 | 6 | 3694_UP | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; PC3; HT_HG-U133A | 6.20e-06 | 200 | 52 | 6 | 4075_DN | |
| Disease | aortic aneurysm | 1.21e-04 | 10 | 49 | 2 | EFO_0001666 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 1.76e-04 | 12 | 49 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | 4.20e-04 | 1392 | 49 | 9 | EFO_0005763 | |
| Disease | pallidum volume change measurement, age at assessment | 7.91e-04 | 25 | 49 | 2 | EFO_0008007, EFO_0021494 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LFPSPFPSCYTSCWF | 21 | Q9Y3F1 | |
| SQYAQAPCCPRICFP | 481 | A6NF34 | |
| RTPDTCPLFCDFYNP | 1146 | Q9HC84 | |
| CYPKCPPSQPFFNED | 1196 | Q9HC84 | |
| SYCPSCRYPCFPTDL | 326 | P15918 | |
| QYCDSLYVPCAPSPC | 216 | P0DPK3 | |
| QYCDSLYVPCAPSPC | 216 | Q04721 | |
| FNYTTAPCCPSDINP | 366 | Q5VTL7 | |
| CAYPTCFPLTQFTCN | 971 | Q07954 | |
| LCPIFCDYYNPPHEC | 1116 | Q02817 | |
| FCYNTPGSFTCQCKP | 816 | P14543 | |
| EPPDFCCPKCQYQAP | 391 | Q9Y6K9 | |
| VFLLPACLYPFASCC | 86 | Q6TCH4 | |
| DPCNPCYPCGSRFSC | 231 | Q14990 | |
| MTFDCCYCPPPPCQE | 31 | Q96BW5 | |
| PNCAVPCYQPSFSAD | 216 | Q13467 | |
| PEFYNCSLPACTFTP | 351 | Q9BYE9 | |
| TYFCPCPCGDNFSIT | 21 | Q9H4G8 | |
| PYCVPCYDNTFANTC | 26 | Q13643 | |
| FFCCFRDYNVEAPPP | 46 | O15194 | |
| FCNNFIGGYFCSCPP | 146 | P09871 | |
| CCPVCEDPVYPFNNP | 386 | Q9NZV1 | |
| ECVNQPGTYFCSCPP | 261 | Q9UBX5 | |
| YEPCATPCFKTCSDP | 1376 | Q3ZCN5 | |
| CFCPTNFPSSMYCDN | 66 | Q99983 | |
| FTSERNCTCFPCPYK | 31 | Q8IWZ5 | |
| LCPSSCDFCYEFPFP | 281 | O75900 | |
| CEFPYEFCTVCFSPF | 241 | P57071 | |
| CFCPPSFPTALYCEN | 46 | O60938 | |
| PCYCGAKSCTAFLPF | 286 | Q53H47 | |
| CEFRPYSCPCPGASC | 121 | Q8IUQ4 | |
| DPPFNCSSGAYSFCC | 71 | B8ZZ34 | |
| ECYCPPDFPSALYCD | 76 | P51888 | |
| NLCPEYPVFCPNNCA | 186 | O00463 | |
| YTCTCPQGFSGPFCE | 1096 | O75094 | |
| CPCCTFVPSNNYIIP | 226 | P61812 | |
| FPCPFCHFCCPERKF | 51 | Q5EBN2 | |
| QAGPPFFCYTCGKCF | 86 | Q9NU63 | |
| CCPYCSFLSPESSQV | 981 | Q9C0A1 | |
| FSCCNPSSPRPCIQY | 211 | P23942 | |
| PYPCPDCPKSFCYPS | 146 | Q86XF7 | |
| SYEFQKPSLCFCCPE | 376 | A6NH21 | |
| CSPVDCPITCTYPFH | 661 | Q96DN2 | |
| NPSETYPAFCTTCFP | 416 | Q96GW9 | |
| VSSSPFYCQPCLDCG | 131 | Q93038 | |
| FPCPVCRFCFPYKSF | 51 | Q495X7 | |
| CCFCLPPYTLPDVAE | 841 | Q9Y5L0 | |
| SQPAAPCPFQCYCFG | 21 | P0DKB5 | |
| FCAVCGFPSPYTCVS | 116 | O43257 | |
| FCVNPCFPDPCKAFV | 281 | Q9Y6M5 | |
| PQPAYFFCPSTLCSS | 76 | Q14679 | |
| LNASYPYCCRPPCET | 361 | A0A286YF58 | |
| TTLCPYFNPCNCVIP | 466 | Q9C030 | |
| SPYFKENSAFPPFCC | 161 | O60635 | |
| FCPLECPAYSSYTNC | 2206 | Q9Y493 | |
| FLDRYCPPNCPPSFF | 566 | P53667 |